238 related articles for article (PubMed ID: 7506125)
21. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
Crickard K; Gross JL; Crickard U; Yoonessi M; Lele S; Herblin WF; Eidsvoog K
Gynecol Oncol; 1994 Nov; 55(2):277-84. PubMed ID: 7959296
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB
J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542
[TBL] [Abstract][Full Text] [Related]
23. Expression of the fibroblast growth factor receptor-1 in human normal tissues and tumors determined by a new monoclonal antibody.
Morikawa Y; Ishihara Y; Tohya K; Kakudo K; Seo MK; Matsuura N
Arch Pathol Lab Med; 1996 May; 120(5):490-6. PubMed ID: 8639054
[TBL] [Abstract][Full Text] [Related]
24. Expression of fibroblast growth factor receptors in human leukemia cells.
Armstrong E; Vainikka S; Partanen J; Korhonen J; Alitalo R
Cancer Res; 1992 Apr; 52(7):2004-7. PubMed ID: 1372535
[TBL] [Abstract][Full Text] [Related]
25. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
[TBL] [Abstract][Full Text] [Related]
26. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE.
Tannheimer SL; Rehemtulla A; Ethier SP
Breast Cancer Res; 2000; 2(4):311-20. PubMed ID: 11056689
[TBL] [Abstract][Full Text] [Related]
27. Akt interaction with PLC(gamma) regulates the G(2)/M transition triggered by FGF receptors from MDA-MB-231 breast cancer cells.
Browaeys-Poly E; Perdereau D; Lescuyer A; Burnol AF; Cailliau K
Anticancer Res; 2009 Dec; 29(12):4965-9. PubMed ID: 20044603
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of fibroblast growth factor 8 in human breast cancer.
Marsh SK; Bansal GS; Zammit C; Barnard R; Coope R; Roberts-Clarke D; Gomm JJ; Coombes RC; Johnston CL
Oncogene; 1999 Jan; 18(4):1053-60. PubMed ID: 10023681
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor-10 and fibroblast growth factor receptors 1-4: expression and peptide localization in human decidua and placenta.
Anteby EY; Natanson-Yaron S; Hamani Y; Sciaki Y; Goldman-Wohl D; Greenfield C; Ariel I; Yagel S
Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):27-35. PubMed ID: 15734081
[TBL] [Abstract][Full Text] [Related]
30. [Molecular mechanism of androgen-dependent transformation--analysis using serum-free culture system].
Koga M; Kouhara H; Sato B
Hum Cell; 1993 Sep; 6(3):176-81. PubMed ID: 8297813
[TBL] [Abstract][Full Text] [Related]
31. FGF19 exhibits neuroprotective effects on adult mammalian photoreceptors in vitro.
Siffroi-Fernandez S; Felder-Schmittbuhl MP; Khanna H; Swaroop A; Hicks D
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1696-704. PubMed ID: 18385093
[TBL] [Abstract][Full Text] [Related]
32. Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.
Kornmann M; Lopez ME; Beger HG; Korc M
Int J Pancreatol; 2001; 29(2):85-92. PubMed ID: 11876253
[TBL] [Abstract][Full Text] [Related]
33. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
[TBL] [Abstract][Full Text] [Related]
34. A soluble dominant negative fibroblast growth factor receptor 4 isoform in human MCF-7 breast cancer cells.
Ezzat S; Zheng L; Yu S; Asa SL
Biochem Biophys Res Commun; 2001 Sep; 287(1):60-5. PubMed ID: 11549253
[TBL] [Abstract][Full Text] [Related]
35. K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors.
Hattori Y; Odagiri H; Katoh O; Sakamoto H; Morita T; Shimotohno K; Tobinai K; Sugimura T; Terada M
Cancer Res; 1992 Jun; 52(12):3367-71. PubMed ID: 1317750
[TBL] [Abstract][Full Text] [Related]
36. De-regulated FGF receptors as therapeutic targets in cancer.
Knights V; Cook SJ
Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
[TBL] [Abstract][Full Text] [Related]
37. Postnatal regulation of fibroblast growth factor ligand and receptor gene expression in rat thoracic aorta.
Winkles JA; Alberts GF; Peifley KA; Nomoto K; Liau G; Majesky MW
Am J Pathol; 1996 Dec; 149(6):2119-31. PubMed ID: 8952544
[TBL] [Abstract][Full Text] [Related]
38. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer.
Leung HY; Gullick WJ; Lemoine NR
Int J Cancer; 1994 Dec; 59(5):667-75. PubMed ID: 7960240
[TBL] [Abstract][Full Text] [Related]
39. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer.
Yoshimura N; Sano H; Hashiramoto A; Yamada R; Nakajima H; Kondo M; Oka T
Clin Immunol Immunopathol; 1998 Oct; 89(1):28-34. PubMed ID: 9756721
[TBL] [Abstract][Full Text] [Related]
40. Altered expression of fibroblast growth factor receptors in human pituitary adenomas.
Abbass SA; Asa SL; Ezzat S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1160-6. PubMed ID: 9100589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
